scispace - formally typeset
Search or ask a question

What are challenges of LTBI treatment in context of healthcare workers? 


Best insight from top research papers

Challenges of latent tuberculosis infection (LTBI) treatment in healthcare workers (HCWs) include perceptions of LTBI as not serious, busy work schedules, side effects of anti-tuberculosis agents, and inconvenience of treatment . Additionally, HCWs may face barriers such as lack of understanding of LTBI, complicated treatment regimens, staffing challenges, and limited patient-provider discussions on LTBI and preventive therapy . Furthermore, challenges in managing LTBI in HCWs involve issues like accurate diagnosis, treatment-related concerns, choice of appropriate treatment regimens, and addressing clinical and epidemiologic complexities . Standardizing LTBI training, improving patient-provider communication, and developing tailored interventions at each stage of the treatment cascade are crucial to enhance LTBI treatment adherence among HCWs .

Answers from top 5 papers

More filters
Papers (5)Insight
Challenges of LTBI treatment in healthcare workers include poor completion rates, influenced by demographic factors for clinic visits and adverse drug effects leading to treatment discontinuation.
Challenges of LTBI treatment for healthcare workers include difficulty in patient identification, language barriers, time constraints, lack of training, treatment complexity, and medication side effects.
Healthcare workers face challenges in understanding LTBI importance, perceiving TPT as complicated, and dealing with clinic staffing constraints, hindering optimal LTBI treatment for PLHIV in Brazil.
Challenges in LTBI care for healthcare workers include accurate diagnosis, managing treatment-related issues, and selecting appropriate treatment regimens due to complex patient characteristics and epidemiologic factors.
Challenges of LTBI treatment in healthcare workers include low acceptance rates, busy schedules, medication side effects, and inconvenience of regular treatment, impacting adherence to prescribed regimens.

Related Questions

What are the challenges in treating TNBC?5 answersThe challenges in treating TNBC include its aggressive nature, lack of therapeutic targets, and limited treatment options. TNBC is the most aggressive subtype of breast cancer and is associated with worse outcomes compared to other subtypes. It does not benefit from hormonal therapy or therapies targeted to HER2. Current treatment options for TNBC are insufficient, and the average survival time for advanced TNBC is shorter than other types of breast cancer. TNBC is characterized by high heterogeneity, making it difficult to develop effective treatments. Additionally, there is a need for predictive biomarkers to identify patients who will respond to treatment. The development of new drugs and targeted therapies specific to TNBC is crucial to improve survival rates and minimize adverse effects.
What are the challenges of TOD?4 answersTransit Oriented Development (TOD) faces several challenges. These challenges include the loss of affordable housing, cost, zoning and regulatory issues, policy consistency and planning coordination, public opposition, and the need for a shared vision among organizations involved in the development process. In low-density contexts, the lack of clear quantified definitions of TOD allows for a more flexible, site-specific understanding to emerge, but all enablers must interact positively for the development to succeed. In the Iranian urban context, challenges include the need for an Iranian version of TOD that considers local conditions, a paradigm shift in government priorities towards mass transit systems, and the integration of transportation and urban planning systems. Overall, the challenges of TOD vary depending on the context, but they often involve issues related to affordability, coordination, and planning.
What are the challenges faced by healthcare workers?5 answersHealthcare workers face various challenges during the COVID-19 pandemic. These challenges include fear of contracting the disease, inadequate protective measures, shortage of manpower, shortage of resources, and the need to prioritize care among patients. Additionally, healthcare workers experience mental health issues, such as burnout and anxiety, and face a widespread shortage of personal protective equipment (PPE). They also encounter challenges at the personal, organizational, and societal levels, including emotional exhaustion, stress, and poor support from society. The limited use of coping strategies by healthcare workers during the pandemic highlights the need for support and assistance in developing effective coping mechanisms. In Africa, healthcare workers face economic insecurity, stressful working conditions, limited access to PPE and resources, social stigma, burnout, and fear for their own safety and the safety of their families. Prioritizing the physical and mental well-being of healthcare workers is crucial in addressing these challenges.
What are the challenges to implementing AI in healthcare?4 answersThe challenges to implementing AI in healthcare include ethical considerations such as transparency, bias, privacy, safety, responsibility, justice, and autonomy. Other challenges include data privacy, regulatory compliance, and the need for appropriate ethical and regulatory frameworks. Additionally, there are challenges related to clinical safety, bias and discrimination, transparency and interpretability, data privacy, integration with existing health systems, and impacts on the healthcare workforce. The process of digitalization and implementation of AI in healthcare also raises technical, ethical, and legal questions that need to be better defined. Harmonized rules on artificial intelligence, privacy and data protection, data quality and management, and the development of regulatory frameworks are crucial for the successful implementation of AI in healthcare.
What are the most common challenges that healthcare organizations face?5 answersHealthcare organizations face several common challenges. One of the main challenges is the insufficient level of readiness to counter cyber security attacks, which has been highlighted by evidence from various sectors and industries, including healthcare. The integration of predictive modeling into personalized-precision healthcare also presents challenges, such as concerns about healthcare infrastructure, technology, and the financial aspect of gene sequencing. Another challenge is the need to effectively develop creativity and innovation among individuals and teams within healthcare organizations, in order to meet the demands of diverse stakeholders and address patient needs. Additionally, healthcare organizations face challenges related to resource management, competition, and the need for better diagnosis and treatment of patients, which require strategic management, education, training, and the application of new technologies.
What are the challenges in implementing multi-professional treatment in a clinical setting?5 answersImplementing multi-professional treatment in a clinical setting presents several challenges. These challenges include the need for a highly specialized multidisciplinary team, the requirement for regional centers of expertise and institutional networks, the time, effort, and financial resources involved, and the importance of effective communication and collaboration across disciplines. In addition, there may be differing opinions among healthcare providers regarding the goals of care, which can be influenced by their own experiences, professions, and personal values. Furthermore, the complexity of chronic pain management requires a multimodal approach involving multiple healthcare professionals from different backgrounds. Lastly, the increasing complexity of healthcare systems and the need for coordination among different disciplines necessitate training healthcare professionals to work effectively and synergistically as teams.

See what other people are reading

Prevalence heart failure medication adherence inclusion and exclusion criteria?
4 answers
The prevalence of heart failure medication adherence varies across studies. In Norway, a study found that 61% of patients initiated dual pharmacotherapy, with only 16% receiving all three recommended drug classes, and significant declines in persistence over time. Another study using liquid chromatography-tandem mass spectrometry found that 82.4% of patients were adherent to prescribed heart failure drugs, with 17.6% being partially or completely non-adherent. In Denmark, advancing age was associated with lower adherence and higher discontinuation rates for ACEi/ARB and BBs, with a 5-year risk of discontinuation increasing with age. A study in Jordan reported that 92.5% of patients had low to moderate medication adherence, with factors like education level, medication-related side effects, and specific drug classes influencing adherence levels. These studies highlight the importance of addressing medication adherence in heart failure management.
FInd competing evidence for the use of levetiracetam in adolescents with epilepsy?
5 answers
Competing evidence exists regarding the use of levetiracetam in adolescents with epilepsy. While Levetiracetam is approved for various types of seizures in adolescents and adults, some studies highlight potential severe psychiatric symptoms induced by levetiracetam, such as hallucinations, delusions, and aggressive behavior, requiring special attention. On the other hand, a study on levetiracetam monotherapy in children with epilepsy showed promising results, with high seizure reduction rates, low serious adverse events, and significant EEG improvements. Additionally, research on patients with status epilepticus demonstrated that high-dose levetiracetam effectively controlled symptoms with a rapid onset, good efficacy, and long action time compared to sodium valproate. However, a digital intervention study found that poor adherence to levetiracetam is common among patients with epilepsy, indicating the need for improved adherence strategies.
What is the influence between comorbilities and drug-resitance tuberculosis?
5 answers
Comorbidities play a significant role in drug-resistant tuberculosis (DR-TB) outcomes, impacting treatment efficacy and patient response. Patients affected by different forms of DR-TB, such as mono-resistant TB, multidrug-resistant TB (MDR-TB), and extensively drug-resistant TB (XDR-TB), exhibit varying responses due to factors like co-infections, genetic background, disease severity, and nutritional status. Additionally, the emergence and spread of TB, including drug-resistant strains, are influenced by health conditions, environmental factors, and socioeconomic status, particularly in regions like Indonesia. Understanding the mechanisms of resistance in Mycobacterium tuberculosis strains is crucial for predicting the global trend of MDR-TB and XDR-TB pandemics, emphasizing the importance of universal access to antimicrobial susceptibility testing endorsed by the World Health Organization.
How does the integration of upstream and downstream strategies affect marketing and communication in a public hospital?
5 answers
The integration of upstream and downstream strategies in a public hospital significantly impacts marketing and communication efforts. By adopting Integrated Marketing Communication (IMC) elements like advertising, personal selling, public relations, direct marketing, and word of mouth activities, hospitals can effectively inform consumers about their services and increase brand equity. Additionally, the strategic use of institutional communications, covering internal and external communication channels, helps hospitals position themselves strategically in the marketplace. Implementing marketing communication strategies has been shown to positively impact hospital performance, promoting health, patient satisfaction, and providing a competitive advantage. Therefore, a holistic approach that combines both upstream (internal) and downstream (external) strategies is crucial for public hospitals to thrive in today's competitive healthcare environment.
What are the potential benefits and challenges associated with deprescribing in nursing homes?
5 answers
Deprescribing in nursing homes presents both benefits and challenges. The potential benefits include improving outcomes by managing polypharmacy, reducing the prevalence of inappropriate medications like benzodiazepine receptor agonists, and addressing harmful prescribing cascades, such as the co-prescribing of anticholinergics and cholinesterase inhibitors. However, challenges exist, such as the complexity of the deprescribing process, internal and external factors influencing practice, and the need to target barriers like knowledge and skills gaps, automatic medication refilling, and poor resident involvement. Overcoming these challenges through collaboration among healthcare professionals, addressing knowledge gaps, and involving residents in decision-making can lead to successful deprescribing in nursing homes, benefiting residents and the healthcare system.
What is the impact of social context on outcomes for those with first episode psychosis?
5 answers
The social context significantly influences outcomes for individuals experiencing first-episode psychosis (FEP). Research indicates that social functioning, recreational activities, and independence-performance outcomes differ across cultural contexts, with varying levels of expectations and cultural determinants impacting functional outcomes. Moreover, neighborhood vulnerability and risk of social exclusion have been linked to greater functional disability in individuals with FEP, emphasizing the role of contextual factors in patient assessments. Additionally, negative symptoms have been identified as the primary predictor of social and role functioning in early psychosis, mediating the relationship between cognition and functional outcomes, highlighting the importance of addressing negative symptoms for improved functional outcomes in FEP. These findings underscore the necessity of tailored interventions considering social contexts to enhance outcomes for individuals with FEP.
Is selexipag more safe and effective vs placebo in treatment for patients with pulmonary arterial hypertension?
5 answers
Selexipag, an oral prostacyclin receptor agonist, has shown efficacy in treating pulmonary arterial hypertension (PAH). Studies indicate that selexipag improves patients' quality of life, is well-tolerated, and can lead to clinical improvement in PAH patients, including those transitioning from intravenous therapies. Additionally, selexipag has demonstrated effectiveness in reducing Raynaud's phenomenon and digital ulcers in systemic sclerosis patients. However, while selexipag has shown stability or improvement in PAH risk scores for most patients, some experienced disease progression or intolerance, necessitating alternative therapies. Overall, selexipag appears to be a safe and effective treatment option for PAH patients, but further research is needed to identify the patients who would benefit the most from this therapy.
How does dengue affect the health and development of children?
5 answers
Dengue significantly impacts children's health and development. Maternal dengue infections have been linked to negative birth outcomes, including low birth weight and increased hospitalizations for up to three years after birth. Children under 15 years are increasingly affected by severe dengue, with rising cases and deaths reported in Brazil and Colombia. Clinical manifestations in children include fever, vomiting, myalgia, and abdominal pain, with complications such as hemorrhagic manifestations, hepatomegaly, and pleural effusion. Severe forms of dengue can lead to hemorrhage and shock, especially in children, emphasizing the need for clinical prevention through vaccines like CYD-TDV and TAK-003, which have shown efficacy in preventing severe dengue in children. Dengue's impact on children's health underscores the importance of early detection, prompt management, and vaccination efforts to mitigate its effects.
How do social determinants contribute to the development of drug-resistant tuberculosis?
5 answers
Social determinants play a crucial role in the development of drug-resistant tuberculosis (DR-TB). Factors such as social vulnerability, low socio-economic status, inadequate housing, overcrowding, and behavioral aspects like smoking contribute significantly to the emergence of DR-TB. Studies highlight that social stigma, living conditions (e.g., one- and two-roomed houses), previous TB treatment history, low body mass index, and pulmonary TB type are key determinants associated with DR-TB development. Additionally, multidimensional poverty, inadequate housing, poor physical environment, and comorbidities are identified as influential factors in the transmission and progression of DR-TB. Addressing these social determinants through interventions like mental health services, nutritional support, and proper housing can aid in mitigating the burden of DR-TB.
What are the coping mechanism of individuals affected by schistosomiasis?
5 answers
Individuals affected by schistosomiasis employ various coping mechanisms to deal with the physical and psychological challenges posed by the disease. Patients with advanced schistosomiasis often experience negative emotions, such as anxiety and irritability, highlighting the need for psychological support in nursing care. Moreover, the impact of severe forms of schistosomiasis, like hepatosplenic schistosomiasis (HS) and schistosomal myeloradiculopathy (SMR), significantly lowers the overall quality of life, emphasizing the importance of multidisciplinary clinical management to improve patient well-being. Additionally, the review on schistosomiasis suggests exploring the role of Universal Stress Proteins (USPs) in the coping mechanisms of the schistosome parasite, potentially leading to the development of new therapeutic interventions against the disease.
What are the research gaps of willingness to enroll for CBHI among informal sectors in Lao PDR?
5 answers
The research gaps regarding the willingness to enroll in Community-Based Health Insurance (CBHI) among informal sectors in Lao PDR include the need to address factors influencing enrollment incentives, such as the impact of health service utilization, knowledge about CBHI, and occupation. Additionally, there is a gap in understanding the causal effects of benefit package components on enrollment probabilities and the distribution of willingness to pay (WTP) in response to policy changes, particularly focusing on the importance of round-trip transportation insurance coverage. Furthermore, there is a gap in exploring the association between risk preferences of individuals and their likelihood of purchasing CBHI, emphasizing the significance of risk aversion towards probability prospects in decision-making. These gaps highlight the complexity of factors influencing CBHI enrollment among informal sectors in Lao PDR and the need for further research to enhance understanding and promote enrollment.